Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Palantir stock rises on UBS coverage, army deal

Investing.com — Palantir Technologies Inc . (NASDAQ:PLTR) stock climbed 3% following a new coverage initiation by UBS and news of an extended partnership with the U.S. Army. The rebound comes after a 3.9% decline on Wednesday, which was influenced by the market’s reaction to hawkish comments from the Federal Reserve.

UBS analyst Karl Keirstead initiated coverage on Palantir with a Neutral rating and an $80 price target, citing a very positive outlook on the company’s fundamentals and revenue growth projections for 2025/2026 that surpass Street consensus by 200 basis points. Keirstead’s assessment is based on conversations with 17 large Palantir customers, aiming to demystify the core functions of Palantir’s offerings and their potential uplift from AI-Data exposure. Despite the positive forecast, Keirstead noted that the company’s current valuation was a factor in the neutral stance, with Palantir trading at 49 times revenue and 124 times free cash flow based on 2025 estimates, which he found challenging to justify.

In a separate development, Palantir announced an extension of its long-standing partnership with the U.S. Army. The agreement, valued at approximately $400.7 million for up to four years, with a ceiling of $618.9 million, supports the “Army Data Platform” (ADP) through the Army Vantage capability. This deal underscores Palantir’s continuing role in providing data analytics solutions to the military sector and may contribute to investor confidence in the company’s ability to secure substantial government contracts.

The UBS analyst was quoted saying, “2025/2026 estimates that are well above the Street consensus (+200bps on revs growth) and a very positive view of the fundamentals.” This commentary reflects a belief in Palantir’s strong future revenue growth and fundamental business strengths, even as the valuation remains a point of caution for the analyst.

Investors appear to have responded favorably to the combination of UBS’s coverage and the significant army contract, resulting in today’s uplift in Palantir’s stock price. As the company continues to navigate its position in the competitive data analytics market, these developments could be critical in shaping its financial trajectory and market valuation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com